课题基金 / 基金详情

Development of diagnostic systems, reference collections and molecular epidemiology studies for important arboviral pathogens of livestock in India

Development of diagnostic systems, reference collections and molecular epidemiology studies for important arboviral pathogens of livestock in India
开发印度牲畜重要虫媒病毒病原体的诊断系统、参考资料和分子流行病学研究
批准号:
BB/L004690/1
负责人:
Peter Mertens
金额:
$101.46万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Peter Mertens的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project "Development of diagnostic systems, reference collections and molecular epidemiology studies for important arboviral pathogens of livestock in India" will build on established links between colleagues at The Pirbright Institute, the University of Glasgow, The John Innes Institute and the Royal Veterinary College (in the UK) with The University of Veterinary and Animal Sciences at Hisar in India, creating links with colleagues working with arboviruses in southern India. Outbreaks of arboviral diseases are a significant burden on livestock / farming communites in India. Serological data show that 21 of the 26 bluetongue virus (BTV) seroptypes exist in India, one of the highest levels of BTV diversity anywhere in the world. The severity of BT outbreaks in Indian sheep has increased significantly in recent decades, reaching 30% in some areas, possibly due to introduction of exotic strains. However, very few Indian BTV isolates have been genetically or phenotypically characterised, creating a major barrier to local validation of diagnostics and to control strategies, including development of vaccines. During the past 25 years, multiple strains of BTV and other arboviruses have emerged in Europe, possibly linked to changes in climate and global trade. However, a lack of data concerning global strain-diversity and distribution limits our ability to understand, respond to and control these events. The incomplete nature of the global database for BTV limits our ability to Identify the geographic origin of BT outbreak-strains. Similar problems exist for many endemic arboviruses in India (Myers et al 1971; Padbidri et al 2002). We will address these knowledge-gaps by isolating, identifying and characterising arboviruses from India, to study their distribution, abundance, relationships, and movements that result in disease outbreaks. The primary focus of the project is BTV, although diagnostic samples used to detect and isolate viruses, will also provide materials and potentially isolates of other arboviruses from the region. The reference collection at Pirbright provides different orbiviruses and sequence data, for development and evaluation of diagnostic assays (by RT-PCR). These assays, which identified the BTV types that invaded Europe since 1998, have become widely accepted 'front-line' tools for diagnosis, surveillance and typing of BTV around the world. However they have not yet been widely validated or deployed in India. BTV Isolates from the Pirbright collection were also used to develop / evaluate inactivated vaccine strains that successfully eradicated BTV type 8 from the UK and northern Europe . Well characterised and documented virus isolates will be generated in India, as a basis for a reference collection of 'Indian arboviruses', focussing particularly on BTV and the other orbiviruses. This will provide materials for local development of relevant vaccines (seed stocks and challenge strains) and validation / further-development of diagnostic assays for identification, detection and surveillance of these viruses on the Indian subbcontinent. Linking 'Indian-reference-collections', to the existing collection at Pirbright, will add to the global resources and our knowledge concerning these viruses. Diagnosis, isolations, sequencing, phylogenetics and virus storage will be undertaken in India, with assistance from Pirbright. Phylogenetic and evolutionary analyses will be performed at Pirbright and Glasgow. Pathology studies will be carried out at Pirbright, at the RVC and in India. The project will take advantage of recent developments in plant-based expression technologies at John Innes (JIC) (P3), to generate low-cost reagents for BTV serotyping. This will create links between plant and animal science in the UK and in India. Development of next generation serological assays will take place at JIC and Pirbright, for evaluation at Pirbright and in India.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Encyclopedia of Virology
病毒学百科全书
DOI: 10.1016/b978-0-12-814515-9.00110-7
发表时间: 2021
期刊:
影响因子: --
作者: [Bingham R]
通讯作者: Bingham R
DOI: 10.1371/journal.pone.0093758
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Bachanek-Bankowska K, Maan S, Castillo-Olivares J, Manning NM, Maan NS, Potgieter AC, Di Nardo A, Sutton G, Batten C, Mertens PP]
通讯作者: Mertens PP
DOI: 10.3390/v7052185
发表时间: 2015-04-28
期刊: Viruses
影响因子: --
作者: [Belaganahalli MN, Maan S, Maan NS, Brownlie J, Tesh R, Attoui H, Mertens PP]
通讯作者: Mertens PP
India link project for molecular epidemiology studies and orbivirus reference collection.
  • 批准号:
    BB/H531478/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $3.26万
  • 财政年份:
    2010
  • 负责人:
    Peter Mertens
  • 依托单位:
Molecular and reverse genetics studies of orbivirus transmission host responses epidemiology and diagnostic systems
  • 批准号:
    BB/I017259/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $108.5万
  • 财政年份:
    2010
  • 负责人:
    Peter Mertens
  • 依托单位:
Expression and formulation of bluetongue virus genes and proteins for development of effective vaccination strategies. THIS GRANT IS A SUPPLEMENTATION
  • 批准号:
    BB/H531151/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $8.89万
  • 财政年份:
    2009
  • 负责人:
    Peter Mertens
  • 依托单位:
Bluetongue virus transmission between ruminant host and Culicoides vectors: the importance of insect saliva proteins
  • 批准号:
    BB/F00852X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $70.07万
  • 财政年份:
    2008
  • 负责人:
    Peter Mertens
  • 依托单位:
国内基金
海外基金
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
  • 批准号:
    82372328
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    项盈
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: